Nonpartisan civic infrastructure
AllCiv·Legis1
·

S.Amdt. 1039

AmendmentFederalSenatePassed Senate
S.Amdt.1039 - To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.
About This Bill
Passed
Latest Action · May 9, 2007
Amendment SA 1039 not agreed to in Senate by Yea-Nay Vote. 46 - 47. Record Vote Number: 154.
Congress
110th (2007–2009)
Introduced
May 3, 2007
Cosponsors (4)
3D 1R

Summary

No plain-language summary has been published yet. A summary is written once the bill text is available.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.